Actinic Keratosis
Also known as: Solar keratosis, Sun spots (precancerous)
An actinic keratosis is a rough, scaly patch of skin that develops after years of sun exposure. It is most common on areas that have received the most ultraviolet light over a lifetime: the face, ears, scalp of people with thinning hair, backs of the hands, forearms, and lower legs. Actinic keratoses are regarded as precancerous, because a small proportion can progress to squamous cell carcinoma, a form of skin cancer, and because having them signals that the surrounding skin has had enough sun damage to be at risk. They are very common in fair-skinned people over 40 who have spent a lot of time outdoors. Treatment is straightforward and effective, and diligent sun protection prevents new ones from forming.
Last updated November 10, 2026
Understanding Actinic Keratosis
An actinic keratosis (AK) is a patch of abnormal, sun-damaged keratinocytes in the top layer of the skin, felt as a rough, sandpapery spot long before it is easily seen. It is among the most common reasons for a visit to a US dermatologist, and an estimated 40 million to 58 million Americans have at least one. Prevalence climbs with age and fairness: about 11 to 26 percent of US adults overall, more than half of fair-skinned people over 60 in sunny regions, and up to 60 percent of older Australians. Men are affected more than women, mainly through outdoor work and scalp exposure. Any single lesion carries a small risk of becoming squamous cell carcinoma (SCC), around 0.6 percent per year in the largest prospective study, but because people typically have many and the surrounding skin is equally damaged, about 65 percent of SCCs arise from a pre-existing AK. Organ transplant recipients, whose suppressed immune system cannot clear damaged cells, develop them faster and have a 65- to 100-fold higher SCC risk.
Ultraviolet B light is absorbed directly by DNA and creates characteristic mutations, most importantly in the TP53 tumor-suppressor gene, which normally orders a damaged cell to repair itself or die. A cell that has lost that brake keeps dividing, and after decades the sun-exposed skin becomes a patchwork of mutant clones, a state called field cancerization. An AK is the first clone big enough to feel. Pathologists grade lesions from thin (grade I) to thick and horny (grade III), but thickness does not predict which will progress. The natural history is unpredictable: within a year, roughly 15 to 60 percent of lesions regress on their own, a similar number persist, a small fraction progress to SCC, and about 15 percent of those that cleared come back. Immunosuppression, whether from transplant drugs, chronic lymphocytic leukemia or HIV, tilts the balance toward progression. Red flags that a lesion may already be cancer are firmness, a diameter over 1 cm, rapid growth, bleeding, ulceration and tenderness; any of these warrants a biopsy rather than freezing.
The 2021 American Academy of Dermatology guideline strongly recommends cryotherapy for individual lesions and 5-fluorouracil (5-FU) cream, imiquimod or photodynamic therapy for areas with many. Cryotherapy clears 39 to 83 percent of lesions depending on how long the freeze is held; longer freezes clear more but scar more. The best head-to-head field evidence is a 2019 Dutch trial of 624 people with at least five scalp or face lesions: 12 months after treatment, 74.7 percent of those who used 5-FU twice daily for 4 weeks had at least a 75 percent reduction in lesions, against 53.9 percent for imiquimod, 37.7 percent for photodynamic therapy and 28.9 percent for ingenol mebutate (since withdrawn). Field treatment also prevents cancer: in a Veterans Affairs trial of 932 people, one course of 5-FU to the face and ears cut the number of SCCs needing surgery by 75 percent over the following year. Daily sunscreen reduced new AKs by about a third and increased spontaneous remission in a 7-month Australian trial.
Only one supplement has good evidence: nicotinamide, the non-flushing form of vitamin B3. In the ONTRAC trial, 386 Australians with prior skin cancers who took 500 mg twice daily for 12 months developed 23 percent fewer new skin cancers and 13 percent fewer AKs than placebo, and the benefit faded within 6 months of stopping. A 2023 trial in 158 transplant recipients found no benefit. Oral retinol at 25,000 IU a day reduced new SCCs by 26 percent in a 2,297-person trial of people with multiple AKs, but that dose exceeds the safe upper limit and is used only under specialist supervision. Several popular products are useless or harmful: beta-carotene did nothing for skin cancer in the Nambour trial, selenium 200 mcg increased SCC risk by 25 percent in the Nutritional Prevention of Cancer trial, an antioxidant combination raised skin cancer rates in women in the French SU.VI.MAX study, and apple cider vinegar, tea tree oil and especially black salve (a corrosive paste on the FDA's list of fake cancer treatments) burn healthy skin while leaving cancer behind.
The most common mistake is to treat the spots and ignore the field. Freezing the five lesions you can feel does nothing for the hundreds of mutant clones around them, so new ones appear within months and people conclude treatment failed. People with multiple lesions in one area do better with a field treatment every year or two, plus cryotherapy for the thick stragglers, and a skin check every 6 to 12 months. The second mistake is abandoning sunscreen once the lesions are gone, or applying it only at the beach: the trial evidence for fewer AKs and fewer SCCs comes from daily, every-season use on the face, neck, ears, hands and forearms, with about a teaspoon for the face and neck alone. The third is quitting a 5-FU course in week two because the skin looks alarming; the redness and crusting are the treatment working, and stopping early is the main reason the cream appears not to work. Call the clinic rather than stopping if the reaction is painful or weeping.
At a Glance
- Common symptoms
- A rough, dry, or scaly patch of skin, often easier to feel than to see, Patches that are flat or slightly raised and usually less than 2 cm across, Pink, red, brown, or skin-coloured patches, sometimes with a hard, wart-like surface
- Main treatments
- Cryotherapy: freezing individual lesions with liquid nitrogen, the most common treatment, Prescription creams or gels applied over several weeks to treat an area with multiple lesions, such as 5-fluorouracil, imiquimod, diclofenac, or tirbanibulin, Photodynamic therapy: a light-sensitising cream followed by exposure to a special light, useful for large areas
- Category
- Dermatological · Very common in fair-skinned adults over 40, especially in sunny climates
- See a doctor if
- Any new rough, scaly, or persistent patch on sun-exposed skin that lasts more than a few weeks
Symptoms
Causes
- Cumulative damage to skin cells from ultraviolet (UV) light from the sun
- UV exposure from tanning beds and sunlamps
- Damage to DNA in skin cells that leads to abnormal growth of the top layer of the skin
- A weakened immune system, which reduces the body's ability to repair and clear sun-damaged cells
Risk Factors
- Fair skin, blond or red hair, and blue or green eyes
- Age over 40, with risk increasing each decade
- A history of frequent sunburn or long-term outdoor work or hobbies
- Living in a sunny climate or at high altitude
- A weakened immune system, including from organ transplant medication
- Previous actinic keratoses or skin cancer
Diagnosis
- Examination of the skin by a doctor, often with a dermatoscope (a magnifying light)
- Skin biopsy if a lesion is thick, bleeding, growing quickly, or has not responded to treatment, to rule out skin cancer
- A full skin check for other sun-damaged areas and for skin cancers
Treatment
- Cryotherapy: freezing individual lesions with liquid nitrogen, the most common treatment
- Prescription creams or gels applied over several weeks to treat an area with multiple lesions, such as 5-fluorouracil, imiquimod, diclofenac, or tirbanibulin
- Photodynamic therapy: a light-sensitising cream followed by exposure to a special light, useful for large areas
- Curettage (scraping) or surgical removal of thick or suspicious lesions, with the tissue sent for examination
- Chemical peels or laser resurfacing for widespread damage in selected cases
- Regular follow-up skin checks, since new lesions commonly develop
- Supportive: daily broad-spectrum sunscreen, which has been shown to reduce new actinic keratoses and help existing ones regress
Natural remedies for actinic keratosis: what the evidence says
Ranked by the strength of human evidence for actinic keratosis specifically. These sit alongside medical care, not in place of it.
Nicotinamide (vitamin B3)
Moderate evidenceIn the ONTRAC trial (386 high-risk adults, 12 months), nicotinamide 500 mg twice daily reduced new non-melanoma skin cancers by 23 percent and actinic keratoses by 11 to 13 percent at 9 to 12 months compared with placebo; an earlier phase 2 study found 29 to 35 percent fewer AKs after 4 months. The effect wore off within 6 months of stopping, and the 2023 ONTRANS trial in 158 organ transplant recipients showed no benefit. The form matters: nicotinic acid (niacin) has not been tested and causes flushing.
- Studied dose
- 500 mg nicotinamide (niacinamide) twice daily, taken continuously; it does not cause flushing at this dose.
- Cautions
- Well tolerated; mild nausea in a few people. Do not substitute niacin or sustained-release niacin, which cause flushing and liver strain at these doses. If you have had a transplant, discuss it with your dermatologist, since the evidence does not support it there.
Vitamin A (oral retinol)
Preliminary evidenceIn the Southwest Skin Cancer Prevention Study, 2,297 adults with 10 or more actinic keratoses were randomized to 25,000 IU of retinol daily or placebo for a median of 3.8 years; new squamous cell carcinomas fell by 26 percent (hazard ratio 0.74) but basal cell carcinomas did not change. A companion trial in people with prior skin cancers found no benefit, and prescription acitretin is used instead in transplant recipients. The dose studied is above the 10,000 IU tolerable upper limit for adults.
- Studied dose
- 25,000 IU retinol daily was studied; this is a specialist-supervised dose, not a self-care one. Dietary vitamin A and beta-carotene do not substitute.
- Cautions
- Teratogenic, so strict contraception is required; raises liver enzymes and triglycerides, dries skin and lips, and long-term intake above 10,000 IU is linked to hip fracture. Avoid with isotretinoin, acitretin, methotrexate and heavy alcohol use.
Omega-3 (EPA)
Preliminary evidenceOmega-3 fats blunt the UV-induced immune suppression that lets damaged cells escape. In a 3-month placebo-controlled trial of 79 people, about 4 g of EPA daily roughly halved the suppression of skin immune responses after a sunburn-level UV dose, and an earlier 42-person trial found the same dose raised the UV dose needed to burn and lowered UV-induced p53 in skin. No trial has counted actinic keratoses or skin cancers, so this is mechanistic support only.
- Studied dose
- About 4 g EPA daily (5 g combined EPA and DHA) was studied for 3 months; 1 to 2 g is the usual practical dose.
- Cautions
- At 4 g daily, bleeding with anticoagulants and antiplatelets and an increased risk of atrial fibrillation in cardiology trials; fishy aftertaste. It does not replace sunscreen or treatment.
What matters day to day
- Apply a broad-spectrum SPF 30 or higher sunscreen to the face, ears, neck, scalp (if thinning), hands and forearms every morning, all year, and reapply every 2 hours outdoors: daily use cut new actinic keratoses by about a third in a 7-month trial and reduced squamous cell carcinomas by about 40 percent over 4.5 years in the Nambour trial.
- Wear a hat with a brim of at least 3 inches, UPF 50 long sleeves and sunglasses, and plan outdoor time outside 10 a.m. to 4 p.m. when the UV index is 3 or above: a brimmed hat alone blocks roughly half the UV reaching the nose and cheeks, where most lesions occur.
- Check your own skin once a month under good light and have anything new, growing, bleeding, tender, thicker than 1 mm or wider than 1 cm looked at within a few weeks: these features mark the lesions most likely to be early squamous cell carcinoma.
- Never use a tanning bed: indoor tanning raises squamous cell carcinoma risk by about two thirds, and the UV dose per session is up to 10 times that of midday sun.
- If you take transplant or other immunosuppressant medication, see a dermatologist every 6 to 12 months and ask about acitretin: your lesions progress faster and the usual chemoprevention with nicotinamide did not work in the transplant trial.
- Use an SPF 30 lip balm and reapply it often: actinic damage on the lower lip (actinic cheilitis) is more likely to progress and lip cancers spread more readily than those on other skin.
Prevention
- Apply broad-spectrum sunscreen (SPF 30 or higher) daily to exposed skin, and reapply every two hours outdoors
- Wear a wide-brimmed hat, sunglasses, and long sleeves in strong sun
- Seek shade between late morning and mid-afternoon when UV is strongest
- Never use tanning beds
- Check your skin regularly and have new or changing patches reviewed
- Ask your doctor about nicotinamide (vitamin B3) supplements, which have reduced new lesions in some studies of high-risk people
When to See a Doctor
- Any new rough, scaly, or persistent patch on sun-exposed skin that lasts more than a few weeks
- A lesion that becomes thicker, tender, bleeds, ulcerates, or grows rapidly, which may indicate skin cancer
- An actinic keratosis that returns after treatment
- You have many lesions, a weakened immune system, or a history of skin cancer and need a regular skin check
Frequently Asked Questions
References
- Eisen DB, Asgari MM, Bennett DD, et al.. Guidelines of care for the management of actinic keratosis. Journal of the American Academy of Dermatology (2021)
- Jansen MHE, Kessels JPHM, Nelemans PJ, et al.. Randomized trial of four treatment approaches for actinic keratosis. New England Journal of Medicine (2019)
- Weinstock MA, Thwin SS, Siegel JA, et al.. Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial. JAMA Dermatology (2018)
- Chen AC, Martin AJ, Choy B, et al.. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine (2015)
- Allen NC, Martin AJ, Snaidr VA, et al.. Nicotinamide for skin-cancer chemoprevention in transplant recipients. New England Journal of Medicine (2023)
- Criscione VD, Weinstock MA, Naylor MF, et al.. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer (2009)
- Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. New England Journal of Medicine (1993)
- Moon TE, Levine N, Cartmel B, et al.. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Cancer Epidemiology, Biomarkers and Prevention (1997)
- Duffield-Lillico AJ, Slate EH, Reid ME, et al.. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. Journal of the National Cancer Institute (2003)
- MedlinePlus Medical Encyclopedia. Actinic keratosis (2024)
Related Conditions
Have questions about Actinic Keratosis?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.